TABAK.PR - Risk

Solid Quality Asset with Moderate Fluctuation

Healthy balance: Exemplary business financials (Health Score: 70/100) paired with moderate price swings for a single equity (±14.0% p.a.). The score (5/7) reflects the standard baseline for equities under SRI rules.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.1x).

Beta (Market Relation)

0.13x

Defensive

Volatility (5Y p.a.)

14.0% p.a.

5-Year Horizon

Max Drawdown (5Y)

-17.9%

5-Year Horizon

Sharpe Ratio

-0.01

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-1.1%
3 Years	14.1%	-12.6%	-0.05	+1.8%
5 Years	14.0%	-17.9%	-0.01	+2.4%
10 Years	15.4%	-30.5%	0.07	+3.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Strong Long-Term Stability: The stock exhibits consistently low volatility across 5 and 10 years (<16% p.a.).